3 research outputs found
Total Synthesis of (−)-Blepharocalyxin D and Analogues
An efficient strategy for the total synthesis of (−)-blepharocalyxin D and an analogue is described. The key step involves an acid-mediated cascade process in which reaction of methyl 3,3-dimethoxypropanoate with γ,δ-unsaturated alcohols possessing diastereotopic styrenyl groups gives <i>trans</i>-fused bicyclic lactones with the creation of two rings and four stereocenters in one pot
Silyl Migrations in d‑Xylose Derivatives: Total Synthesis of a Marine Quinoline Alkaloid
A versatile method for the synthesis of orthogonally protected d-xylose 1-thioethers is described using unusual silyl group migrations which were pivotal in the synthesis of 4,8-dimethyl-6-<i>O</i>-(2′,4′-di-<i>O</i>-methyl-β-d-xylopyranosyl)hydroxyquinoline confirming the structure and absolute configuration of the natural product
Design and Nuclear Magnetic Resonance (NMR) Structure Determination of the Second Extracellular Immunoglobulin Tyrosine Kinase A (TrkAIg2) Domain Construct for Binding Site Elucidation in Drug Discovery
The tyrosine kinase A (TrkA) receptor
is a validated therapeutic
intervention point for a wide range of conditions. TrkA activation
by nerve growth factor (NGF) binding the second extracellular immunoglobulin
(TrkAIg2) domain triggers intracellular signaling cascades. In the
periphery, this promotes the pain phenotype and, in the brain, cell
survival or differentiation. Reproducible structural information and
detailed validation of protein–ligand interactions aid drug
discovery. However, the isolated TrkAIg2 domain crystallizes as a β-strand-swapped
dimer in the absence of NGF, occluding the binding surface. Here we
report the design and structural validation by nuclear magnetic resonance
spectroscopy of the first stable, biologically active construct of
the TrkAIg2 domain for binding site confirmation. Our structure closely
mimics the wild-type fold of TrkAIg2 in complex with NGF (1WWW.pdb), and the <sup>1</sup>H–<sup>15</sup>N correlation spectra confirm that both
NGF and a competing small molecule interact at the known binding interface
in solution